Cargando…

Transcriptome analysis reveals a long non-coding RNA signature to improve biochemical recurrence prediction in prostate cancer

Despite highly successful treatments for localized prostate cancer (PCa), prognostic biomarkers are needed to improve patient management and prognosis. Accumulating evidence suggests that long noncoding RNAs (lncRNAs) are key regulators with biological and clinical significance. By transcriptome ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jinyuan, Lan, Yujia, Yu, Fulong, Zhu, Shiwei, Ran, Jianrong, Zhu, Jiali, Zhang, Hongyi, Li, Lili, Cheng, Shujun, Xiao, Yun, Li, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982764/ https://www.ncbi.nlm.nih.gov/pubmed/29861844 http://dx.doi.org/10.18632/oncotarget.25048

Ejemplares similares

Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer
por: Shao, Ning, et al.
Publicado: (2019)

Transcriptome analysis reveals a reprogramming energy metabolism-related signature to improve prognosis in colon cancer
por: Zhang, Xinxin, et al.
Publicado: (2020)

Gene Perturbation Atlas (GPA): a single-gene perturbation repository for characterizing functional mechanisms of coding and non-coding genes
por: Xiao, Yun, et al.
Publicado: (2015)

The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer
por: Liu, Chunhui, et al.
Publicado: (2022)

Dysregulated long intergenic non-coding RNA modules contribute to heart failure
por: Pang, Lin, et al.
Publicado: (2016)

5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer
por: Wang, Ke, et al.
Publicado: (2021)

Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
por: Su, Qiang, et al.
Publicado: (2021)

Multiphoton Microscopy for Identifying Collagen Signatures Associated with Biochemical Recurrence in Prostate Cancer Patients
por: Pavlova, Ina P., et al.
Publicado: (2021)

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
por: Ke, Zhi-Bin, et al.
Publicado: (2022)

Protein-network modeling of prostate cancer gene signatures reveals essential pathways in disease recurrence
por: Chen, James L, et al.
Publicado: (2011)

A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma
por: Xu, Zijun, et al.
Publicado: (2021)

An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
por: Zhang, Guian, et al.
Publicado: (2021)

A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer
por: Xia, Zhongyou, et al.
Publicado: (2023)

A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy
por: Li, Xiang, et al.
Publicado: (2020)

Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer
por: Lv, Daojun, et al.
Publicado: (2021)

Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
por: Zhao, Erjie, et al.
Publicado: (2020)

Study on the role of SLC14A1 gene in biochemical recurrence of prostate cancer
por: Ye, Bin, et al.
Publicado: (2022)

Identification of genes that predict the biochemical recurrence of prostate cancer
por: Chu, Jianfeng, et al.
Publicado: (2018)

Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer
por: Han, Chenglin, et al.
Publicado: (2023)

Biochemical recurrence related metabolic novel signature associates with immunity and ADT treatment responses in prostate cancer
por: Wang, Xuan, et al.
Publicado: (2022)

Identification of Potential Predictor of Biochemical Recurrence in Prostate Cancer
por: Wei, Jingchao, et al.
Publicado: (2022)

Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer
por: Zhan, Yao, et al.
Publicado: (2018)

Integrative analysis of the expression profiles of whole coding and non-coding RNA transcriptomes and construction of the competing endogenous RNA networks for chronic obstructive pulmonary disease
por: Feng, Xueyan, et al.
Publicado: (2023)

Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
por: Li, Chun, et al.
Publicado: (2022)

Assessment of biochemical recurrence of prostate cancer (Review)
por: Lin, Xiaozeng, et al.
Publicado: (2019)

Prognostic impact of a lymphocyte activation-associated gene signature in GBM based on transcriptome analysis
por: Lan, Yujia, et al.
Publicado: (2021)

Construction of DNA methylation-based nomogram for predicting biochemical-recurrence-free survival in prostate cancer
por: Zhu, Jiayu, et al.
Publicado: (2022)

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
por: Grant, Delores J., et al.
Publicado: (2017)

Predicting biochemical recurrence of prostate cancer with artificial intelligence
por: Pinckaers, Hans, et al.
Publicado: (2022)

Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer
por: Long, Gongwei, et al.
Publicado: (2021)

A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy
por: Zhang, Qijie, et al.
Publicado: (2020)

A Novel Angiogenesis-Related Gene Signature to Predict Biochemical Recurrence of Patients with Prostate Cancer following Radical Therapy
por: Fan, Bohan, et al.
Publicado: (2022)

Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy
por: Cai, Yingxin, et al.
Publicado: (2022)

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer
por: Ren, Lei, et al.
Publicado: (2023)

Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer
por: Liu, Bide, et al.
Publicado: (2020)

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence
por: Xiang, Yu-zhu, et al.
Publicado: (2013)

A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
por: Shi, Run, et al.
Publicado: (2019)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
por: Lacy, John M., et al.
Publicado: (2016)

A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer
por: Gu, Chengyuan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fqmbr11o54urb97tmmckrhe3rf